Cell-Mediated Immunity in Diabetes Mellitus

Cell-mediated immunity in diabetes mellitus.

Cell-mediated immunity was evaluated in patients with diabetes mellitus by delayed hypersensitivity skin tests and in vitro lymphocyte transformations. Only 44% of diabetic patients had skin test reactivity to Candida antigen, compared with 88% of normal controls (P < 0.001). Insulin-dependent diabetic (IDD) patients had abnormally low lymphocyte transformation responses to phytohemagglutinin, ...

Metabolomics and Cell Therapy in Diabetes Mellitus

Diabetes with a broad spectrum of complications has become a global epidemic metabolic disorder. Till now, several pharmaceutical and non-pharmaceutical therapeutic approaches were applied for its treatment. Cell-based therapies have become promising methods for diabetes treatment. Better understanding of diabetes pathogenesis and identification of its specific biomarkers along with evaluation ...

EVALUATION OF CELL-MEDIATED IMMUNITY IN MUSTARD GAS INJURIES

Yamakido, et al. in 1986 have studied immunological parameters in poison gas workers, and a depression has been observed in immunologic response. Also, the frequency of cancer has reached as high as five-fold that of the general population. In the present study, cell-mediated immunity (CMI) was measured in three groups of Iranian mustard gas-injured patients. The first group were those wh...

Estimation Cell Mediated Immunity in Some Iraqi Patients with Type 1 and 2 Diabetes Mellitus

Cell-mediated immunity was estimated in diabetic patients by evaluation a level of CD4 and CD8 in type 1 and 2 diabetic patients. Of the 33 patients with type 1 diabetes mellitus 17 were males and 16 were females, as well as the type 2 diabetes mellitus patients were made up of 17 males and 16 females. Both groups attend the outpatient Clinic in the National Diabetes Center, Al-Mustansiriya Uni...

T-cell Mediated Immunity in the Pathogenesis of Insulin-dependent Diabetes Mellitus